NCT02246621 2026-02-03MONARCH 3Eli Lilly and CompanyPhase 3 Active not recruiting493 enrolled 23 charts 1 FDA
NCT03778931 2025-09-15EMERALDStemline Therapeutics, Inc.Phase 3 Completed478 enrolled 16 charts 1 FDA